Dr. John Cush RheumNow
5 years 8 months ago
Among 335 AAV pts, 18% had venous thromboembolism (VTE). The incidence rate of AAV-related VTE was 2.4/100 PYs and was higher in the first 3 months post–AAV diagnosis (20.4/100 PY) and decreased over time. Age & BVAS were predictive of VTE.https://t.co/Arb2gk27B7
Kidney International reports on a series of systemic lupus erythematosus (SLE) patients, who despite inactive urinary sediment and low level proteinuria, had a high rate of glomerulonephritis (GN) proven by renal biopsy; moreover, the LN was not predicted by laboratory abnormalities.
A single center retrospective study included 87 SLE patients with proteinuria <1000 mg/24-hour proteinuria who also had their first kidney biopsy.
Pfizer announced results Wednesday from its FDA-mandated postmarketing safety study of tofacitinib (Xeljanz), and they don't bode well for the drug and possibly others in its class.
Dr. John Cush RheumNow
5 years 8 months ago
QD Clinic - Arthritis and Colitis
https://t.co/U5NrQuIcrd https://t.co/LbuRy9pTIl
Dr. John Cush RheumNow
5 years 8 months ago
Vaccine Rollout: Fed has delivered about 44.4 million Vax doses to states (~24 mill doses given). Estimated 6% (19.9 mill) have had one vax dose and 1% (3.5 mill) 2 doses. 2.7 of 3 million elderly in nursing homes long-term-care have recv >= 1 vax dose .https://t.co/HaoIRP4Uoo
Dr. John Cush RheumNow
5 years 8 months ago
Rheumatologists Rank 2nd in Physician Burnout
The 2021 Medscape Survey on Physician burnout ranks rheumatology second, just behind Critical Care medicine.
https://t.co/nIDqa5TCqG https://t.co/psem4wYIlN
Dr. John Cush RheumNow
5 years 8 months ago
ACR Convergence 2020 Fireside Chats- top presentations in nr-axSpA, AS, axial PsA and Still’s disease.
Sponsored by Novartis Medical Affairs
Unable to attend the key sessions at #ACR20? Listen to the experts as they weigh in on the top abstracts.
https://t.co/oGwmEXNaur https://t.co/qjwfaXXnXQ
Dr. John Cush RheumNow
5 years 8 months ago
The risk of RA was studied in cohort of 14,463 endometriosis pts. RA risk was higher in those w/ endometriosis [adjusted HR 1.75), and also w/ age ≥45 years (adj HR 1.50) or with autoimmune disease (adj HR 6.99). https://t.co/sPouzyFI3H https://t.co/lDjSgLxXfV
Dr. John Cush RheumNow
5 years 8 months ago
13 patients with SAPHO syndrome with nail lesions and palmoplantar pustulosis were treated wtih tofacitinib with significant improvement in nail scores (58-77%), psoriasis scores, QOL, DQLI and acute phase reactants. https://t.co/J8yB4pRHS1
Dr. John Cush RheumNow
5 years 8 months ago
Rheums: Got a Rheumatology question or case for RheumNow? Record it here and we'll feature it on an upcoming podcast. Tell us your name and where you practice rheumatology.
https://t.co/wzNmOzH4VE https://t.co/6w8CAAUkO6
Dr. John Cush RheumNow
5 years 8 months ago
RheumNow COVID-19 Updates
https://t.co/TiB7739ONL
Acute gout has its well defined protocols, and most state that urate lowering therapy (ULT) should be continued; but does ULT affect outcomes in an acute gout attack?
